MOTS-C Research Hub · Evidence Overview

MOTS-C research evidence: what has actually been studied?

A review of the mitochondrial-derived peptide MOTS-C, from its discovery and cell biology to animal metabolic models and limited human observations.

JD BioWorks Research LibraryPublished: July 15, 2026Last reviewed: July 15, 2026Editorial review: JD BioWorks Research Library

Evidence at a glance

Human evidenceLimited. Observational and small physiology-focused studies do not establish therapeutic efficacy or general safety.

Preclinical evidenceSubstantial discovery-stage work includes cell metabolism, AMPK-related signaling, mouse metabolic models, and stress-response research.

Evidence gapControlled human intervention evidence, pharmacokinetics, dose–response, and long-term safety remain limited.

ScopeEndogenous MOTS-C biology and results from synthetic peptide experiments are related but not interchangeable evidence questions.

Interpretation note: Findings must stay tied to the exact molecule, formulation, model, population, and endpoint studied. A biological signal is not, by itself, proof of safety or effectiveness.

Overview

MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region. Its discovery expanded interest in short open reading frames within mitochondrial DNA as sources of signaling peptides. Research has examined cellular metabolism, stress responses, nuclear translocation, exercise, aging, and metabolic models.

Research background

The 2015 discovery paper reported that MOTS-C influenced folate-cycle-linked purine biosynthesis and AMPK-related metabolic signaling in cells, and altered insulin sensitivity and diet-related phenotypes in mice. Subsequent work explored endogenous concentrations and associations in people. These strands should be separated: endogenous association does not establish what an administered synthetic material will do.

Findings by research area

Research area	What has been reported	What it does not establish
Cell metabolism	The discovery study reported effects on folate-cycle-linked purine synthesis and AMPK signaling.	A therapeutic mechanism in humans.
Mouse models	Researchers reported changes in insulin sensitivity and diet-related metabolic phenotypes.	Human clinical efficacy or safety.
Human observations	Studies have measured endogenous MOTS-C or examined exercise-related associations.	Effects of administering synthetic MOTS-C.

Human evidence

Human data

Human research is much less mature than the preclinical literature. Measurements of endogenous MOTS-C and associations with age, exercise, or metabolic variables can generate hypotheses, but they do not determine causality or the effects of an exogenous research material. Adequate randomized intervention trials were not identified for this summary.

Preclinical evidence

Animal data

The original mouse experiments reported protection against age- and diet-related insulin resistance and diet-induced obesity under the tested conditions. Replication, model selection, sex, age, strain, exposure, and outcome definitions are important when judging translation.

Laboratory evidence

In-vitro and analytical context

Cell studies have examined metabolic pathways, stress responses, and intracellular localization. Because MOTS-C may act in a context-dependent manner, cell type, nutrient state, concentration, and exposure time should be reported precisely.

Research limitations

Human intervention evidence is sparse.
Endogenous associations do not establish effects of administered peptide.
Preclinical metabolic outcomes may not translate across species.
Identity, stability, and exposure of synthetic preparations require independent confirmation.

Future research

Future work should clarify human pharmacokinetics, endogenous-versus-exogenous biology, dose–response, tissue distribution, and long-term safety through staged, independently replicated studies.

Primary references

Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015. doi:10.1016/j.cmet.2015.02.009.

Article record

Research question: What does the published evidence on MOTS-C show across human, animal, and laboratory research?
Evidence cutoff: July 15, 2026
Article status: Published educational research summary; not independently peer reviewed
Author: JD BioWorks Research Library
Editorial review: JD BioWorks Research Library
Planned review cycle: At least annually, or sooner if material evidence or regulatory information changes

This article summarizes published research for educational and laboratory-information purposes. It is not medical advice, does not provide instructions for personal use, and does not establish that any material is safe or effective for human or veterinary use.

CONTINUE YOUR REVIEW

Next steps for qualified researchers

Use the public documentation resources below, then continue to Research Product Access when you are ready to review the gated catalog.

Search Certificates of Analysis Match available analytical records to the named product, quantity, and lot. Explore Research Guides Review HPLC, LC-MS, purity, identity, storage, and traceability guidance. Get Research Product Access Complete the Research Use Acknowledgment to create an account and receive automatic product access.

For qualified laboratory, analytical, educational, or institutional research only. Not for human or veterinary use.